drugset / Trial / NCT02237183
Iloprost in Preventing Lung Cancer in Former Smokers
Non-randomizedParallel-groupDouble-blindPrevention
Summary
This phase I trial studies the side effects and best dose of iloprost compared with a placebo in preventing lung cancer in former smokers. Chemoprevention is the use of drugs to keep cancer from forming or coming back. Inhaled iloprost may help prevent lung cancer from forming in patients who used to smoke and who have been found to have abnormal cells in their mucus.
Timeline
- Start
- 2015-11-05
- Primary completion
- 2020-03-05
- Completion
- 2023-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloprost | Other / unclassified | — | Inhaled |